Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Fujii

Showing results (171-180 of 197) with videos related to

Pageof 20
Sort By:
International Journal of Clinical Oncology|June 19, 2017
Matched-pair analysis of patients with advanced hypopharyngeal cancer: surgery versus concomitant chemoradiotherapyShigemichi Iwae, Masato Fujii, Ryuichi Hayashi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 15, 2020
Assessment of Immune-Related Interstitial Lung Disease in Patients With NSCLC Treated with Immune Checkpoint Inhibitors: A Multicenter Prospective StudyYuzo Suzuki, Masato Karayama, Tomohiro Uto, et al.
BMC Pulmonary Medicine|October 3, 2021
Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysisKoichi Miyashita, Masato Karayama, Yusuke Inoue, et al.
Clinical Lung Cancer|November 3, 2025
Biological Aging and Survival Outcomes in Patients With Advanced Non-Small Cell Lung Cancer Receiving Systemic TherapySuguru Kojima, Yusuke Inoue, Masato Karayama, et al.
BMC Pulmonary Medicine|October 8, 2024
Risk factors for relapse of immune-related pneumonitis after 6-week oral prednisolone therapy: a follow-up analysis of a phase II studyMasato Karayama, Naoki Inui, Yusuke Inoue, et al.
Journal for Immunotherapy of Cancer|July 27, 2023
Six-week oral prednisolone therapy for immune-related pneumonitis: a single-arm phase II studyMasato Karayama, Naoki Inui, Yusuke Inoue, et al.
Annals of Surgical Oncology|February 21, 2014
Lymph node metastasis in t4 maxillary sinus squamous cell carcinoma: incidence and treatment outcomeAkihiro Homma, Ryuichi Hayashi, Kazuto Matsuura, et al.
JTO Clinical and Research Reports|July 4, 2025
Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort StudiesYusuke Inoue, Yoshihiro Kitahara, Masato Karayama, et al.
Cancer Immunology, Immunotherapy : CII|June 6, 2021
Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancerMasato Karayama, Naoki Inui, Yusuke Inoue, et al.
Hinyokika Kiyo. Acta Urologica Japonica|January 7, 2020
[The Safety of Laparoscopic Radical Cystectomy during Initial Phases in a Japanese Multicenter Cohort]Toru Kanno, Takahiro Inoue, Katsuhiro Ito, et al.
Pageof 20

Showing results (171-180 of 197) with videos related to

Sort By:
Pageof 20
International Journal of Clinical Oncology|June 19, 2017
Matched-pair analysis of patients with advanced hypopharyngeal cancer: surgery versus concomitant chemoradiotherapyShigemichi Iwae, Masato Fujii, Ryuichi Hayashi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 15, 2020
Assessment of Immune-Related Interstitial Lung Disease in Patients With NSCLC Treated with Immune Checkpoint Inhibitors: A Multicenter Prospective StudyYuzo Suzuki, Masato Karayama, Tomohiro Uto, et al.
BMC Pulmonary Medicine|October 3, 2021
Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysisKoichi Miyashita, Masato Karayama, Yusuke Inoue, et al.
Clinical Lung Cancer|November 3, 2025
Biological Aging and Survival Outcomes in Patients With Advanced Non-Small Cell Lung Cancer Receiving Systemic TherapySuguru Kojima, Yusuke Inoue, Masato Karayama, et al.
BMC Pulmonary Medicine|October 8, 2024
Risk factors for relapse of immune-related pneumonitis after 6-week oral prednisolone therapy: a follow-up analysis of a phase II studyMasato Karayama, Naoki Inui, Yusuke Inoue, et al.
Journal for Immunotherapy of Cancer|July 27, 2023
Six-week oral prednisolone therapy for immune-related pneumonitis: a single-arm phase II studyMasato Karayama, Naoki Inui, Yusuke Inoue, et al.
Annals of Surgical Oncology|February 21, 2014
Lymph node metastasis in t4 maxillary sinus squamous cell carcinoma: incidence and treatment outcomeAkihiro Homma, Ryuichi Hayashi, Kazuto Matsuura, et al.
JTO Clinical and Research Reports|July 4, 2025
Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort StudiesYusuke Inoue, Yoshihiro Kitahara, Masato Karayama, et al.
Cancer Immunology, Immunotherapy : CII|June 6, 2021
Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancerMasato Karayama, Naoki Inui, Yusuke Inoue, et al.
Hinyokika Kiyo. Acta Urologica Japonica|January 7, 2020
[The Safety of Laparoscopic Radical Cystectomy during Initial Phases in a Japanese Multicenter Cohort]Toru Kanno, Takahiro Inoue, Katsuhiro Ito, et al.
Pageof 20